EPITOME-4, an open-label phase 3b study evaluating a new formulation of epoprostenol sodium in Japanese pulmonary arterial hypertension patients following switch from Flolan

被引：0
|
作者：
Tamura, Y. [1 ]
Ono, T. [1 ]
Fukuda, K. [1 ]
Satoh, T. [2 ]
Sasayama, S. [3 ]
机构：
[1] Keio Univ, Sch Med, Tokyo, Japan
[2] Kyorin Univ, Sch Med, Tokyo, Japan
[3] Doshisha Univ, Kyoto 602, Japan
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：41 / 41
页数：1
相关论文
共 48 条
  • [1] EPITOME-4, a phase 3b study evaluating a new formulation of epoprostenol sodium in pulmonary arterial hypertension following switch from Flolan®
    Tamura, Yuichi
    Ono, Tomohiko
    Fukuda, Keiichi
    Satoh, Toru
    Sasayama, Shigetake
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [2] Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with Pulmonary Arterial Hypertension (EPITOME4)
    Yuichi Tamura
    Tomohiko Ono
    Keiichi Fukuda
    Toru Satoh
    Shigetake Sasayama
    [J]. Advances in Therapy, 2013, 30 : 459 - 471
  • [3] Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with Pulmonary Arterial Hypertension (EPITOME4)
    Tamura, Yuichi
    Ono, Tomohiko
    Fukuda, Keiichi
    Satoh, Toru
    Sasayama, Shigetake
    [J]. ADVANCES IN THERAPY, 2013, 30 (05) : 459 - 471
  • [4] EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension
    Sitbon, Olivier
    Delcroix, Marion
    Bergot, Emmanuel
    Boonstra, Anco B.
    Granton, John
    Langleben, David
    Escribano Subias, Pilar
    Galie, Nazzareno
    Pfister, Thomas
    Lemarie, Jean-Christophe
    Simonneau, Gerald
    [J]. AMERICAN HEART JOURNAL, 2014, 167 (02) : 210 - 217
  • [5] Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)
    Yuichi Tamura
    Tomohiko Ono
    Keiichi Fukuda
    Toru Satoh
    Shigetake Sasayama
    [J]. Advances in Therapy, 2013, 30 (5) : 554 - 555
  • [6] Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study
    Chin, Kelly M.
    Badesch, David B.
    Robbins, Ivan M.
    Tapson, Victor F.
    Palevsky, Harold I.
    Kim, Nick H.
    Kawut, Steven M.
    Frost, Adaani
    Benton, Wade W.
    Lemarie, Jean-Christophe
    Bodin, Frederic
    Rubin, Lewis J.
    McLaughlin, Vallerie
    [J]. AMERICAN HEART JOURNAL, 2014, 167 (02) : 218 - +
  • [7] Investigation of safety and efficacy of the new more thermostable formulation of Flolan (epoprostenol) in Japanese patients with pulmonary arterial hypertension (PAH)-An open-label, single-arm study
    Mihara, Kazuko
    Ogawa, Aiko
    Matsubara, Hiromi
    Terao, Takumi
    Ichikawa, Yoshitaka
    [J]. PLOS ONE, 2018, 13 (04):
  • [8] EPITOME-2: Evaluation of a new formulation of epoprostenol sodium in pulmonary arterial hypertension patients switched from an originally approved formulation
    Sitbon, Olivier
    Delcroix, Marion
    Bergot, Emmanuel
    Boonstra, Anco
    Escribano Subias, Pilar
    Galie, Nazzareno
    Granton, John
    Langleben, David
    Pfister, Thomas
    Lemarie, Jean-Christophe
    Simonneau, Gerald
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [9] Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors
    Hoeper, Marius M.
    Klinger, James R.
    Benza, Raymond L.
    Simonneau, Gerald
    Langleben, David
    Naeije, Robert
    Corris, Paul A.
    [J]. RESPIRATORY MEDICINE, 2017, 122 : S18 - S22
  • [10] Safely Transitioning from Inhaled Iloprost to Inhaled Treprostinil Sodium - Results from a Multicenter Open-Label Study in Patients with Pulmonary Arterial Hypertension
    Bourge, R. C.
    Tapson, V. F.
    Safdar, Z.
    Benza, R. L.
    Channick, R. N.
    Rosenzweig, E. B.
    Shapiro, S.
    McSwain, C. S.
    Gotzkowsky, A.
    Nelsen, A.
    Rubin, L. J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S71 - S72
12345